lumbar disc herniation and lumbar spinal stenosis.
Conditions
Interventions
Intervention group: steroid-hyaluronic-acid, control group:steroid-hyaluronidase.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: patients aged 20 to 65 years with a BMI <33 with radicular back pain of lumbar disc origin that has not responded to conservative treatments within 6 weeks of treatment. Positive MRI findings of intervertebral disc herniation and canal stenosis or intervertebral foramen stenosis and positive clinical tests in favor of intervertebral disc involvement and lumbar root involvement in EMG/NCS
Exclusion criteria
Exclusion criteria: Neurological deficits such as muscle weakness or symptoms of cauda equina syndrome, multi-root and bilateral involvement, bone stenosis and stenosis due to ligamentous hypertrophy, history of back surgery, vascular problems of the lower extremities and vascular claudication, history of lower extremities surgery, unstable hemodynamic conditions, sensitivity to drugs used in the study, use of corticosteroids (last 2 weeks), presence of coagulation disorders or uncontrolled systemic problems, uncontrolled diabetes, uncontrolled blood pressure, presence of systemic infection or infection at the injection site, pregnancy, presence of neurological diseases such as MS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| . Timepoint: . Method of measurement: .;Pain and function. Timepoint: Before the intervention, 1 month, 3 months and 6 months after the intervention. Method of measurement: Pain assessment with visual analog scale, function assessment with Roland-Morris questionnaire and Oswestry Disability Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactseyed Ahmad Raeissadat
Shahid Beheshti University of Medical Sciences
Outcome results
None listed